Biography
Norma is currently a Post-Doctoral Associate with the Galluzzi Lab, in the Department of Radiation Oncology at Weill Cornell Medical College (New York), where she investigates the mechanisms through which HR+ breast cancer resists PD-1 blockers. Prior to joining the Galluzzi Lab (2019), she was a Post-Doctoral Associate with the Kroemer Lab at the Cordeliers Research Center (Paris, France) and the Gustave Roussy Cancer Center (Villejuif, France; 2017-2018) after receiving her M.Sc. in Biology of Health (2013) and her Ph.D. (2017) from Paris Saclay University (Paris, France). Norma has a long-standing interest in deciphering the antigenic and adjuvant components of anticancer immune responses in the context of therapeutic success and failure.
(Co)-first Authored Publications
- Charpenter, M., Bloy, N., Formenti, S.C., et al. Live imaging to quantify cellular radiosensitivity in patient-derived tumor organoids. J Vis Exp, 2024. IN PRESS.
- Álvarez-Abril, B., Bloy, N., Galassi, C. et al. Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods Cell Biol, 2022. 172: p. 17-36.
Abstracts Selected for Poster Presentation (First/co-first and last/co-last only)
- Bloy, N., Buqué. A., Iribarren C., et al. Breaking through the resistance of HR+ breast cancer patients to immune checkpoints blockers. 38th SITC Meeting (November 2023).
- Bloy, N., Buqué. A., Petroni, G. et al. Breaking through the resistance of breast cancer to immune checkpoint blockers in a unique mouse model of HR+ disease. 36th Annual SITC Meeting (November 2021).
- Bloy, N., Buqué. A., Petroni, G. et al. Immunological characterization of mouse HR+ mammary tumors progressing after radiation therapy. AACR Radiation Science and Medicine Meeting (March 2021).
My Bibliography Link
https://www.ncbi.nlm.nih.gov/myncbi/norma.bloy.1/bibliography/public/